| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6cb7a0a91bb1b458787f21794a256b9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2209-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-581
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01D5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3317
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3368 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-0206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01D5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31568 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01D5-14 |
| filingDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3afb674b94c3f440363cc391d7c6d55f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2309237c3cf92a551485ea0e85cfef2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddb7f1e43fe7afcc4163c79cd7937a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16cc6599b67fe7746bf78e9dbe22fc39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d269bafc9543ea6907d80f2875e77e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d884e7dfebc88af54a7e66867e3f3e41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6c65b69fa875842a9e488a989b4d2db |
| publicationDate |
2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108025142-A |
| titleOfInvention |
Dose control system for an injectable drug delivery device and related method of use |
| abstract |
The present invention relates to a dose control system for an injectable drug delivery device comprising a substantially elongated drug delivery body, at least one injectable drug contained by the body, the body having a distal end and a proximal end, wherein The dose control system includes three-dimensional magnetic field generating means for generating a magnetic field along three axes (x, y, z); magnetic field detection means configured to detect changes in at least the magnetic field generated by the three-dimensional magnetic field generating means; displacement detection means, configured to measure relative displacement or relative movement of the drug delivery device; and an integrated control unit, wherein the integrated control unit is connected to the magnetic field detection device and to the displacement detection device for processing data from both the magnetic field detection device and the displacement detection device Information; wherein the three-dimensional magnetic field generating device is configured to achieve rotational coaxial displacement around and along the longitudinal axis of the drug delivery device; the magnetic field detection device is positioned along the longitudinal axis; and the three-dimensional magnetic field generating device is located at the proximal end of the drug delivery device body or nearby. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110624160-A |
| priorityDate |
2015-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |